Current Sarcoidosis Models and the Importance of Focusing on the Granuloma gan Landon W. Locke, Larry S. Schlesinger, Elliott D. Crouser

Cael y testun llawn

Current best practice in the management of pulmonary and systemic sarcoidosis gan Emily N. Amin, Douglas R. Closser, Elliott D. Crouser

Cael y testun llawn

An in silico modeling approach to understanding the dynamics of sarcoidosis. gan Baltazar D Aguda, Clay B Marsh, Michael Thacker, Elliott D Crouser

Cael y testun llawn

Design, rationale, and baseline characteristics of a pilot randomized clinical trial of nicotine treatment for pulmonary sarcoidosis gan Erinn M. Hade, Rachel M. Smith, Daniel A. Culver, Elliott D. Crouser

Cael y testun llawn

Digital Imaging Analysis for the Study of Endotoxin-Induced Mitochondrial Ultrastructure Injury gan Mandar S. Joshi, Elliott D. Crouser, Mark W. Julian, Brandon L. Schanbacher, John Anthony Bauer

Cael y testun llawn

Mitochondrial transcription factor A, an endogenous danger signal, promotes TNFα release via RAGE- and TLR9-responsive plasmacytoid dendritic cells. gan Mark W Julian, Guohong Shao, Zachary C Vangundy, Tracey L Papenfuss, Elliott D Crouser

Cael y testun llawn

The landscape of transcriptomic and proteomic studies in sarcoidosis gan Maneesh Bhargava, Shu-Yi Liao, Elliott D. Crouser, Lisa A. Maier, Sonia M. Leach

Cael y testun llawn

Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes. gan Mark W Julian, Heather R Strange, Megan N Ballinger, Richard S Hotchkiss, Tracey L Papenfuss, Elliott D Crouser

Cael y testun llawn

Leveraging in vitro and pharmacokinetic models to support bench to bedside investigation of XTMAB-16 as a novel pulmonary sarcoidosis treatment gan Elliot Offman, Noopur Singh, Mark W. Julian, Landon W. Locke, Landon W. Locke, Sabahattin Bicer, Jonah Mitchell, Thomas Matthews, Kirsten Anderson, Elliott D. Crouser

Cael y testun llawn

SCARLET (Supplemental Citicoline Administration to Reduce Lung injury Efficacy Trial): study protocol for a single-site, double-blinded, placebo-controlled, and randomized Phase 1/... gan Sonal Pannu, Matthew C. Exline, Joseph S. Bednash, Joshua A. Englert, Philip Diaz, Amy Bartlett, Guy Brock, Qing Wu, Ian C. Davis, Elliott D. Crouser

Cael y testun llawn

Early Titration of Oxygen During Mechanical Ventilation Reduces Hyperoxemia in a Pilot, Feasibility, Randomized Control Trial for Automated Titration of Oxygen Levels gan Sonal R. Pannu, MD, MSc, Matthew Exline, MD, MPH, Brett Klamer, MS, Guy Brock, PhD, Elliott D. Crouser, MD, John W. Christman, MD, Philip Diaz, MD

Cael y testun llawn

Therapeutic doses of efzofitimod demonstrate efficacy in pulmonary sarcoidosis gan Ogugua Ndili Obi, Robert P. Baughman, Elliott D. Crouser, Mark W. Julian, Landon W. Locke, Abhijeeth Chandrasekaran, Pavithra Ramesh, Nelson Kinnersley, Vis Niranjan, Daniel A. Culver, Peter H.S. Sporn

Cael y testun llawn

Differential transcriptomics in sarcoidosis lung and lymph node granulomas with comparisons to pathogen-specific granulomas gan Nancy G. Casanova, Manuel L. Gonzalez-Garay, Belinda Sun, Christian Bime, Xiaoguang Sun, Kenneth S. Knox, Elliott D. Crouser, Nora Sammani, Taylor Gonzales, Bhupinder Natt, Sachin Chaudhary, Yves Lussier, Joe G. N. Garcia

Cael y testun llawn